SUBSCRIBE
SUBSCRIBE
News   FDA

EU Approves Novartis Corporation’s Eucreas Diabetes Drug

February 25, 2008 | 
1 min read
ZURICH, Feb 25 (Reuters) - The European Union approved Novartis's Eucreas diabetes pill, the Swiss drugmaker said on Monday, following its approval of Galvus, one of the two-in-one drug's ingredients.
FDA Approvals Europe
MORE ON THIS TOPIC
graphic pattern with the tablet. topic of drugs. pill with girl and space inside. relax
Psychedelics
With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’
September 5, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
September 3, 2025
 · 
3 min read
 · 
Tristan Manalac